Rubella in Europe.

Por Galazka, A.
Publicado em 1991

Eliminating neonatal tetanus--an attainable goal.

Por Cook, R, Galazka, A
Publicado em 1985

Interferon for treatment.

Por Galazka, A., Scott, E.
Publicado em 1988

Immunity against diphtheria in adults in Poland.

Por Galazka, A., Kardymowicz, B.
Publicado em 1989

The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age.

Por Halsey, N., Galazka, A.
Publicado em 1985

Neonatal tetanus in the world today

Por Stanfield, J. P., Galazka, A.
Publicado em 1984

Immunological response to Clostridium botulinum toxin.

Por Galazka, A, Rymkiewicz, D, Aleksandrowicz, J
Publicado em 1988

Mumps and mumps vaccine: a global review.

Por Galazka, A. M., Robertson, S. E., Kraigher, A.
Publicado em 1999

Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems.

Por Dietz, V., Galazka, A., van Loon, F., Cochi, S.
Publicado em 1997

Evaluation of the effect of continuous infusion recombinant interleukin-2 (bioleukin) on peripheral blood leucocytes of patients with terminal malignancy.

Por Oliver, R. T., Crosby, D., Nouri, A., Scott, E., Galazka, A.
Publicado em 1989

Indications and contraindications for vaccines used in the Expanded Programme on Immunization

Por Galazka, A. M., Lauer, B. A., Henderson, R. H., Keja, J.
Publicado em 1984

Indications et contre-indications des vaccins utilisés dans le Programme élargi de vaccination

Por Galazka, A. M., Lauer, B. A., Henderson, R. H., Keja, J.
Publicado em 1984

Atopic manifestations in the acquired immune deficiency syndrome: response to recombinant interferon gamma.

Por Parkin, J M, Eales, L J, Galazka, A R, Pinching, A J
Publicado em 1987

Randomised double-blind trial of recombinant interferon-beta for condyloma acuminatum.

Por Monsonego, J, Cessot, G, Ince, S E, Galazka, A R, Abdul-Ahad, A K
Publicado em 1996

Vacciner les enfants du monde: progrès et perspectives

Por Henderson, R. H., Keja, J., Hayden, G., Galazka, A., Clements, J., Chan, C.
Publicado em 1988

Immunizing the children of the world: progress and prospects.

Por Henderson, R. H., Keja, J., Hayden, G., Galazka, A., Clements, J., Chan, C.
Publicado em 1988

CD3-T cell receptor modulation is selectively induced in CD8 but not CD4 lymphocytes cultured in agar.

Por Oudrhiri, N, Farcet, J P, Gourdin, M F, M'Bemba, E, Gaulard, P, Katz, A, Divine, M, Galazka, A, Reyes, F
Publicado em 1990

Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya.

Por Kok, P. W., Leeuwenburg, J., Tukei, P., van Wezel, A. L., Kapsenberg, J. G., van Steenis, G., Galazka, A., Robertson, S. E., Robinson, D.
Publicado em 1992

The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]

Por Stein, R. C., Malkovska, V., Morgan, S., Galazka, A., Aniszewski, C., Roy, S. E., Shearer, R. J., Marsden, R. A., Bevan, D., Gordon-Smith, E. C.
Publicado em 1991

A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual dis...

Por Gottlieb, D. J., Brenner, M. K., Heslop, H. E., Bianchi, A. C., Bello-Fernandez, C., Mehta, A. B., Newland, A. C., Galazka, A. R., Scott, E. M., Hoffbrand, A. V.
Publicado em 1989